Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
Top Cited Papers
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 358 (9286), 958-965
- https://doi.org/10.1016/s0140-6736(01)06102-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis CHepatology, 2001
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis CHepatology, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Discordance Between Serum Alanine Aminotransferase (ALT) and Virologic Response to IFN-β2b in Chronic Hepatitis C Patients with High and Low Pretreatment Serum Hepatitis C Virus RNA TitersJournal of Interferon & Cytokine Research, 1998
- Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparisonHepatology, 1997
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995
- Histopathology of Hepatitis C Virus InfectionSeminars in Liver Disease, 1995
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assayJournal of General Virology, 1993
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981